EP3119911
Efnasambönd til notkunar við meðhöndlun á Alzheimers-sjúkdómi í ApoE4+/+ sjúklingum
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.3.2015EP published:
9.8.2023EP application number:
15764560.7
EP translation filed:
16.10.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
22.3.2035Expiry date:
22.3.2027Next due date:
31.3.2027
Title in English:
COMPOUNDS FOR USE IN TREATING ALZHEIMER'S DISEASE IN APOE4+/+ PATIENTSLanguage of the patent:
English
Timeline
Today
23.3.2015EP application
9.8.2023EP Publication
16.10.2023Translation submitted
15.11.2023Registration published
22.3.2027Expires
Owner
Name:
Alzheon, Inc.Address:
111 Speen Street Suite 306, Framingham, MA 01701, US
Inventor
Name:
TOLAR, MartinAddress:
Framingham, Massachusetts 01701, US
Name:
HEY, JohnAddress:
Framingham, Massachusetts 01701, US
Name:
KOCIS, PetrAddress:
Framingham, Massachusetts 01701, US
Name:
YU, JeremyAddress:
Framingham, Massachusetts 01701, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461968595 PDate:
21.3.2014Country:
US
Classification
Categories:
A61K 38/05, C12Q 1/68, A61P 25/00, C07D 233/54
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 13.3.2024
Expires: 22.3.2025
Payer: G.H. Sigurgeirsson ehf.
Number: 11
Paid: 11.3.2025
Expires: 22.3.2026
Payer: G.H. Sigurgeirsson ehf.
Number: 12
Paid: 11.3.2026
Expires: 22.3.2027
Payer: G.H. Sigurgeirsson ehf.